WBA Quote, Financials, Valuation and Earnings

HealthWarehouse.com has a net margin of 0.95% compared to Walgreens Boots Alliance's net margin of 0.82%. Walgreens Boots Alliance's return on equity of -24.93% beat HealthWarehouse.com's return on equity of --.

Walgreens Boots Alliance has a consensus price target of --, signalling upside risk potential of 12.7%. On the other hand HealthWarehouse.com has an analysts' consensus of -- which suggests that it could grow by 712.5%. Given that HealthWarehouse.com has higher upside potential than Walgreens Boots Alliance, analysts believe HealthWarehouse.com is more attractive than Walgreens Boots Alliance.

Walgreens Boots Alliance has a beta of 0.664, which suggesting that the stock is 33.636% less volatile than S&P 500. In comparison HealthWarehouse.com has a beta of 0.194, suggesting its less volatile than the S&P 500 by 80.56%.

Walgreens Boots Alliance has a quarterly dividend of $0.25 per share corresponding to a yield of 10.88%. HealthWarehouse.com offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Walgreens Boots Alliance pays -14.59% of its earnings as a dividend. HealthWarehouse.com pays out -- of its earnings as a dividend.

Walgreens Boots Alliance quarterly revenues are $36.4B, which are larger than HealthWarehouse.com quarterly revenues of $9M. Walgreens Boots Alliance's net income of $344M is higher than HealthWarehouse.com's net income of $73.8K. Notably, Walgreens Boots Alliance's price-to-earnings ratio is -- while HealthWarehouse.com's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Walgreens Boots Alliance is 0.05x versus 0.18x for HealthWarehouse.com. Usually stocks with elevated PS ratios are considered overvalued.

Johnson & Johnson has a net margin of 0.95% compared to Walgreens Boots Alliance's net margin of 11.99%. Walgreens Boots Alliance's return on equity of -24.93% beat Johnson & Johnson's return on equity of 20.88%.

Walgreens Boots Alliance has a consensus price target of --, signalling upside risk potential of 12.7%. On the other hand Johnson & Johnson has an analysts' consensus of $172.53 which suggests that it could grow by 19.49%. Given that Johnson & Johnson has higher upside potential than Walgreens Boots Alliance, analysts believe Johnson & Johnson is more attractive than Walgreens Boots Alliance.

Walgreens Boots Alliance has a beta of 0.664, which suggesting that the stock is 33.636% less volatile than S&P 500. In comparison Johnson & Johnson has a beta of 0.505, suggesting its less volatile than the S&P 500 by 49.522%.

Walgreens Boots Alliance has a quarterly dividend of $0.25 per share corresponding to a yield of 10.88%. Johnson & Johnson offers a yield of 3.33% to investors and pays a quarterly dividend of $1.24 per share. Walgreens Boots Alliance pays -14.59% of its earnings as a dividend. Johnson & Johnson pays out 33.48% of its earnings as a dividend. Johnson & Johnson's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Walgreens Boots Alliance quarterly revenues are $36.4B, which are larger than Johnson & Johnson quarterly revenues of $22.5B. Walgreens Boots Alliance's net income of $344M is lower than Johnson & Johnson's net income of $2.7B. Notably, Walgreens Boots Alliance's price-to-earnings ratio is -- while Johnson & Johnson's PE ratio is 24.11x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Walgreens Boots Alliance is 0.05x versus 4.04x for Johnson & Johnson. Usually stocks with elevated PS ratios are considered overvalued.

SunLink Health Systems has a net margin of 0.95% compared to Walgreens Boots Alliance's net margin of -6.93%. Walgreens Boots Alliance's return on equity of -24.93% beat SunLink Health Systems's return on equity of -5.08%.

Walgreens Boots Alliance has a consensus price target of --, signalling upside risk potential of 12.7%. On the other hand SunLink Health Systems has an analysts' consensus of -- which suggests that it could fall by --. Given that Walgreens Boots Alliance has higher upside potential than SunLink Health Systems, analysts believe Walgreens Boots Alliance is more attractive than SunLink Health Systems.

Walgreens Boots Alliance has a beta of 0.664, which suggesting that the stock is 33.636% less volatile than S&P 500. In comparison SunLink Health Systems has a beta of 1.404, suggesting its more volatile than the S&P 500 by 40.425%.

Walgreens Boots Alliance has a quarterly dividend of $0.25 per share corresponding to a yield of 10.88%. SunLink Health Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Walgreens Boots Alliance pays -14.59% of its earnings as a dividend. SunLink Health Systems pays out -- of its earnings as a dividend.

Walgreens Boots Alliance quarterly revenues are $36.4B, which are larger than SunLink Health Systems quarterly revenues of $7.9M. Walgreens Boots Alliance's net income of $344M is higher than SunLink Health Systems's net income of -$549K. Notably, Walgreens Boots Alliance's price-to-earnings ratio is -- while SunLink Health Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Walgreens Boots Alliance is 0.05x versus 0.17x for SunLink Health Systems. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of 0.95% compared to Walgreens Boots Alliance's net margin of 6.11%. Walgreens Boots Alliance's return on equity of -24.93% beat UnitedHealth Group's return on equity of 14.51%.

Walgreens Boots Alliance has a consensus price target of --, signalling upside risk potential of 12.7%. On the other hand UnitedHealth Group has an analysts' consensus of $636.05 which suggests that it could grow by 25.68%. Given that UnitedHealth Group has higher upside potential than Walgreens Boots Alliance, analysts believe UnitedHealth Group is more attractive than Walgreens Boots Alliance.

Walgreens Boots Alliance has a beta of 0.664, which suggesting that the stock is 33.636% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.583, suggesting its less volatile than the S&P 500 by 41.67%.

Walgreens Boots Alliance has a quarterly dividend of $0.25 per share corresponding to a yield of 10.88%. UnitedHealth Group offers a yield of 1.62% to investors and pays a quarterly dividend of $2.10 per share. Walgreens Boots Alliance pays -14.59% of its earnings as a dividend. UnitedHealth Group pays out 30.21% of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Walgreens Boots Alliance quarterly revenues are $36.4B, which are smaller than UnitedHealth Group quarterly revenues of $99.2B. Walgreens Boots Alliance's net income of $344M is lower than UnitedHealth Group's net income of $6.1B. Notably, Walgreens Boots Alliance's price-to-earnings ratio is -- while UnitedHealth Group's PE ratio is 32.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Walgreens Boots Alliance is 0.05x versus 1.21x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.